Kang Qin

<p>Concurrent TP53 mutations predict poor outcomes of EGFR-TKI treatments in Chinese patients with advanced NSCLC</p>

Helei Hou, Kang Qin, Liang Yu et al. · Cancer Management and Research · 2019 · 78 citations · Full text

Medicine, Oncology, Pharmacology +16

Biomimetic Nanotheranostics Camouflaged with Cancer Cell Membranes Integrating Persistent Oxygen Supply and Homotypic Targeting for Hypoxic Tumor Elimination

Hongliang Chen, Donghui Zheng, Wenzhen Pan et al. · ACS Applied Materials & Interfaces · 2021 · 48 citations

Natural Sciences, Materials Science, Oncology +17

Survival-associated alternative splicing signatures in non-small cell lung cancer

Deze Zhao, Chuantao Zhang, Man Jiang et al. · Aging · 2020 · 36 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Identification and validation of key genes with prognostic value in non‐small‐cell lung cancer via integrated bioinformatics analysis

Li Wang, Jialin Qu, Liang Yu et al. · Thoracic Cancer · 2020 · 34 citations · Full text

Medicine, Bioinformatics, Oncology +17

Sulforaphane Exerts Beneficial Immunomodulatory Effects on Liver Tissue via a Nrf2 Pathway-Related Mechanism in a Murine Model of Hemorrhagic Shock and Resuscitation

Weiqiang Liang, Johannes Greven, Kang Qin et al. · Frontiers in Immunology · 2022 · 19 citations · Full text

Life Sciences, Immunology, Pathobiology +17